Mark
Infection
AstraZeaneca
Belgium
Biography
After successfully completing his PhD in 2000, he relocated to Austin, Texas to take up a position at the University of Texas as a postdoctoral research associate. In Austin, he focused on the total synthesis of a natural product. In 2002, he took up a position at AstraZeneca in the Process, Research and Development department in Macclesfield. Since then, he has worked on many projects across the different phases of clinical development and also spent 18 months on secondment in Analytical Science. Recently, he led the development of the DS area of the MEK inhibitor project.
Research Interest
Infection
